Hemosol B0

Hemosol B0 is an electrolyte solution that contains calcium, lactic acid, magnesium, sodium, chloride ion, and hydrogen carbonate. It is supplied as a sterile solution for injection and is used in haemodialysis circuits and as an intravenous electrolyte replacement fluid in clinical settings across the European market.

Hemosol B0 is formulated to provide essential electrolytes and buffering capacity during renal replacement therapy and fluid management.

- Dialysate for haemodialysis procedures. - Intravenous electrolyte replacement in patients with deficits. - Maintenance of fluid and electrolyte balance during major surgery. - Support for patients with metabolic acidosis. - Adjunct therapy in intensive care units for volume resuscitation. - Use in pediatric dialysis when appropriately diluted.

Adverse reactions to Hemosol B0 are generally related to its electrolyte composition and infusion characteristics.

Common: - Mild infusion site irritation or erythema. - Transient nausea or vomiting. - Mild headache. - Temporary changes in serum calcium or magnesium levels. - Mild hypotension related to rapid infusion.

Serious: - Severe hyperkalemia or hypocalcemia if dosing errors occur. - Acute pulmonary edema from fluid overload. - Anaphylactic or severe allergic reaction to solution components. - Metabolic alkalosis from excessive bicarbonate load. - Cardiac arrhythmias secondary to electrolyte imbalance.

When using Hemosol B0, clinicians should consider patient-specific factors and monitor relevant parameters.

- Verify electrolyte levels before and during therapy to avoid imbalances. - Adjust infusion rates in patients with compromised cardiac function. - Use caution in patients with liver disease due to altered lactate metabolism. - Monitor acid‑base status, especially in those prone to metabolic alkalosis. - Ensure compatibility with other intravenous solutions and lines. - Document any allergic reactions to solution constituents. - Follow institutional protocols for dialysate composition adjustments.

Hemosol B0 may interact with other medications or solutions that affect electrolyte or acid‑base balance.

Avoid: - Concurrent administration of high‑dose calcium channel blockers that may exacerbate hypercalcemia. - Use with potassium‑sparing diuretics without electrolyte monitoring. - Mixing with solutions containing high concentrations of chloride that could precipitate.

Use with caution: - Concurrent intravenous bicarbonate therapy. - Loop diuretics that alter sodium and magnesium excretion. - Anticoagulants used during haemodialysis, requiring careful monitoring of volume status. - Medications that affect lactate metabolism, such as metformin. - Blood products that may alter ion concentrations.